Basic information Safety Supplier Related

CEP-37440

Basic information Safety Supplier Related

CEP-37440 Basic information

Product Name:
CEP-37440
Synonyms:
  • CEP-37440
  • 2-[[5-Chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methylbenzamide
  • 2-(5-chloro-2-{(S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino}pyrimidin-4-ylamino)-N-methylbenzamide
  • (S)-2-((5-chloro-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide
  • CEP37440;CEP 37440
  • CS-1603
  • Benzamide, 2-[[5-chloro-2-[[(6S)-6,7,8,9-tetrahydro-6-[4-(2-hydroxyethyl)-1-piperazinyl]-1-methoxy-5H-benzocyclohepten-2-yl]amino]-4-pyrimidinyl]amino]-N-methyl-
  • inhibit,Inhibitor,Cluster of differentiation 246,PTK2,triple-negative breast cancer,inflammatory breast cancer,CEP-37440,Anaplastic lymphoma kinase,FAK1,Anaplastic lymphoma kinase (ALK),Focal adhesion kinase,CEP 37440,PTK2 protein tyrosine kinase 2,autophosphorylation kinase,CD246,FAK,ALK tyrosine kinase receptor
CAS:
1391712-60-9
MF:
C30H38ClN7O3
MW:
580.12
EINECS:
200-258-5
Product Categories:
  • Inhibitors
Mol File:
1391712-60-9.mol
More
Less

CEP-37440 Chemical Properties

Density 
1.300±0.06 g/cm3(Predicted)
storage temp. 
2-8°C(protect from light)
solubility 
DMF: 12 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.3 mg/ml
form 
A crystalline solid
pka
14.57±0.46(Predicted)
color 
Light yellow to yellow
More
Less

CEP-37440 Usage And Synthesis

Uses

CEP-37440 is a highly potent, selective and orally active inhibitor of ALK.

in vivo

CEP-37440 (3-55 mg/kg; p.o.; b.i.d and q.d., for 12 d) inhibits breast tumor growth in Sup-M2 xenograftin SCID mice[2].
CEP-37440 (30 mg/kg; p.o; once, for 24 h) inhibits tyrosine phosphorylation in Sup-M2 xenografts mice[2].
CEP-37440 (55 mg/kg; p.o; once, for 24 h) inhibits FAK phosphorylation in CWR22 xenografts in Nude mice[2].
CEP-37440 (1-10 mg/kg; p.o and i.v.; CD-1 mouse, Sprague-Dawley (SD) rats) has good pharmacokinetic parameters[2].

Pharmacokinetic parameters in CD-1 mouse and Sprague-Dawley (SD) rats[2]

PK parameterCD-1 mouseSD rat
ivdose (mg/kg)11
ivt1/2 (h)3.02
ivAUC0-∞ (ng*h/mL)16124005
ivVd (L/kg)2.70.8
ivCL (mL/min/kg)104
podose (mg/kg)105
poCmax (ng/mL)15331340
Animal Model:SCID/Beige with Sup-M2 xenografts[2]
Dosage:3 mg/kg (b.i.d), 10 mg/kg (b.i.d), 30 mg/kg (b.i.d and q.d. ), and 55 mg/kg (q.d.)
Administration:Oral administration; b.i.d and q.d., for 12 days
Result:Inhibited tumor growth in a dose-dependent manner.
Animal Model:SCID/Beige with Sup-M2 xenografts and Nu/Nu mice female with Sup-M2 xenografts[2]
Dosage:30 mg/kg
Administration:Oral administration; once, for 24 hours
Result:Decreased NPM-ALK phosphorylation (>85%).
Animal Model:Nu/Nu mice female with CWR22 xenografts[2]
Dosage:55 mg/kg
Administration:Oral administration; once, for 24 hours
Result:Inhibited FAK phosphorylation in a time-dependent manner.

CEP-37440Supplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
MedChemexpress LLC
Tel
021-58955995
Email
sales@medchemexpress.cn